TRIP-1: A regulator of osteoblast function

Journal of Bone and Mineral Research

Volumn 27, Issue 7, 2012, Pages 1576-1584

  Metz Estrella, Diana ^a   Jonason, Jennifer H ^a   Sheu, Tzong Jen ^a   Mroczek Johnston, Rachel M ^a   Puzas, J Edward ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Osteoblast; Remodeling; TGF ; TRAP; TRIP 1

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; ANDROSTANOLONE; BONE MORPHOGENETIC PROTEIN 2; COLECALCIFEROL; COLLAGEN TYPE 1; CYCLIN D1; DEXAMETHASONE; ESTRADIOL; LUCIFERASE; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE; PROTEIN; PROTEIN TRIP 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MATURATION; BONE REMODELING; CELL COUNT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; CELL CYCLE; EUKARYOTIC INITIATION FACTORS; FEMALE; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862489790     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1611     Document Type: Article

References (27)

1. Hock JM, Canalis E, Centrella M. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology. 1990 Jan; 126(1):421-6. (Pubitemid 20037172)
2. Yamada T, Kamiya N, Harada D, Takagi M. Effects of transforming growth factor-beta1 on the gene expression of decorin, biglycan, and alkaline phosphatase in osteoblast precursor cells and more differentiated osteoblast cells. Histochem J. 1999 Oct; 31(10):687-94.
3. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res. 1994 Jun; 9(6):855-63.
4. Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature. 1995 Oct 12; 377(6549):548-52.
5. Choy L, Derynck R. The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem. 1998 Nov 20; 273(47):31455-62. (Pubitemid 28533166)
6. Sheu TJ, Schwarz EM, Martinez DA, O'Keefe RJ, Rosier RN, Zuscik MJ, Puzas JE. A phage display technique identifies a novel regulator of cell differentiation. J Biol Chem. 2003 Jan 3; 278(1):438-43. (Pubitemid 36043594)
7. Asano K, Kinzy TG, Merrick WC, Hershey JW. Conservation and diversity of eukaryotic translation initiation factor eIF3. J Biol Chem. 1997 Jan 10; 272(2):1101-9. (Pubitemid 27034605)
8. Masutani M, Sonenberg N, Yokoyama S, Imataka H. Reconstitution reveals the functional core of mammalian eIF3. EMBO J. 2007 Jul 25; 26(14):3373-83. (Pubitemid 47123530)
9. Ahlemann M, Zeidler R, Lang S, Mack B, Münz M, Gires O. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation. Mol Carcinog. 2006 Dec; 45(12):957-67. (Pubitemid 44907385)
10. Joseph P, Lei YX, Whong WZ, Ong TM. Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res. 2002 Feb 1; 62(3):703-7. (Pubitemid 34126944)
11. Zhang L, Pan X, Hershey JW. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem. 2007 Feb 23; 282(8):5790-800. (Pubitemid 47093731)
12. Perez RE, Navarro A, Rezaiekhaligh MH, Mabry SM, Ekekezie II. TRIP-1 regulates TGF-beta1-induced epithelial-mesenchymal transition of human lung epithelial cell line A549. Am J Physiol Lung Cell Mol Physiol. 2011 May; 300(5):L799-807.
13. Sheu TJ, Schwarz EM, O'Keefe RJ, Rosier RN, Puzas JE. Use of a phage display technique to identify potential osteoblast binding sites within osteoclast lacunae. J Bone Miner Res. 2002 May; 17(5): 915-22. (Pubitemid 34441909)
14. Martinez DA, Zuscik MJ, Ishibe M, Rosier RN, Romano PR, Cushing JE, Puzas JE. Identification of functional insulin-like growth factor-II/ mannose-6-phosphate receptors in isolated bone cells. J Cell Biochem. 1995 Oct; 59(2):246-57.
15. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 2001 May 1; 20(9):2254-72. (Pubitemid 32410595)
16. Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet. 2000 Apr 22; 355(9213):1399-403. (Pubitemid 30215962)
17. Stepan JJ, Havrdova E, Tyblova M, Horakova D, Ticha V, Novakova I, Zikan V. Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta. 2004 Oct; 348(1-2):147-54. (Pubitemid 39209013)
18. Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum. 2002 Dec; 46(12):3136-42. (Pubitemid 35453521)
19. Igarashi M, Kamiya N, Hasegawa M, Kasuya T, Takahashi T, Takagi M. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol. 2004 Jan; 35(1):3-10. (Pubitemid 40585329)
20. Smith E, Frenkel B. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J Biol Chem. 2005 Jan 21; 280(3):2388-94.
21. Centrella M, McCarthy TL, Canalis E. Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol. 1991 Sep; 11(9): 4490-6. (Pubitemid 21895845)
22. Rickard DJ, Kazhdan I, Leboy PS. Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone. 1995 Jun; 16(6):671-8.
23. Liu P, Oyajobi BO, Russell RG, Scutt A. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) in vitro. Calcif Tissue Int. 1999 Aug; 65(2):173-80. (Pubitemid 29350658)
24. Kriegel AJ, Fang Y, Liu Y, Tian Z, Mladinov D, Matus IR, Ding X, Greene AS, Liang M. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res. 2010 Dec 1; 38(22):8338-47.
25. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 1992 Oct 30; 71(3):505-14.
26. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993 May; 7(5):812-21. (Pubitemid 23163585)
27. Seo HS, Serra R. Tgfbr2 is required for development of the skull vault. Dev Biol. 2009;334:481-90.